Manufacturing Systems Engineer II
Recor Medical Europe GmbH
Summary
The Manufacturing Systems Engineer II supports the development, validation, implementation, and continuous improvement of manufacturing systems, processes, and production technologies. This role collaborates with cross-functional teams to troubleshoot manufacturing issues, execute engineering changes, maintain manufacturing documentation, and support equipment, software, and process validation activities. This role involves the functional integration of the software, hardware and mechanical aspects of a product, system, or components to ensure that the resulting functionality meets production requirements through verification and validation activities.
Job description
Responsibilities and Duties
- Troubleshoot manufacturing systems and support verification and validation activities through protocol development, execution, and reporting.
- Process Manufacturing Engineering Change Orders (ECOs/ECRs), perform impact assessments, and support implementation of product, process, equipment, and software changes.
- Develop, review, and maintain manufacturing work instructions, SOPs, test methods, and production documentation.
- Support process development efforts to improve scalability, product yield, quality, and manufacturing efficiency.
- Support troubleshooting activities with suppliers and new vendors to support supply continuity and cost reduction efforts.
- Collaborate cross-functionally to evaluate risks, resolve manufacturing issues, and implement cost-effective solutions.
- Assist in the development, testing, validation, and deployment of manufacturing software applications and automated systems.
- Assist with equipment qualification, and manufacturing process validation activities, including IQ/OQ/PQ execution, equipment events, and documentation.
Requirements
- Bachelor/Master of Science degree in Engineering with 2 yrs of experience in medical device industry
- Identify problems or improvement opportunities in existing measurement methods, and system
- Excellent oral and written communication skills
- Self-motivated, action oriented and result oriented
- Understanding of medical device processes and assembly knowledge to drive product yield and performance
- Experience with MATLAB, Python, C++ or other similar tools for software development and instrument control
- CAD experience (SolidWorks) is a plus
Requirements
- Bachelor/Master of Science degree in Engineering
- 2 years of experience in medical device industry
- Identify problems or improvement opportunities in existing measurement methods and systems
- Excellent oral and written communication skills
- Self-motivated, action oriented and result oriented
- Understanding of medical device processes and assembly knowledge to drive product yield and performance
- Experience with MATLAB, Python, C++ or other similar tools for software development and instrument control
- CAD experience (SolidWorks) is a plus
Benefits
- Medical, Dental & Vision
- 401(k) Matching
- Paid Time Off
- Company Holidays
- Annual Incentive Programs
- Long Term Incentive Programs
- Wellness Programs
- Employee Assistance Resources
Company overview
Recor Medical Europe GmbH is the European subsidiary of Recor Medical, an innovative medical technology company headquartered in Palo Alto, California, and a wholly-owned subsidiary of Otsuka Medical Devices Co., Ltd. The company specializes in transforming hypertension management through its pioneering Paradise Ultrasound Renal Denervation (uRDN) system. This minimally invasive medical device utilizes ultrasound technology to perform renal denervation, offering a non-pharmaceutical treatment option for patients with hypertension, the world's leading cardiovascular risk factor. The Paradise system has received FDA approval in the United States, bears the CE mark for European markets, and is an investigational device in Japan. With operations based in Frankfurt, Germany, Recor Medical Europe GmbH focuses on clinical adoption, market access, and commercialization efforts across Europe, the Middle East, and Africa. The company has demonstrated strong clinical evidence through multiple randomized controlled trials and continues to invest in rigorous clinical studies and high-quality product development to establish a solid foundation for widespread clinical adoption of this groundbreaking hypertension therapy.